Acasti Pharma | ACST - Net Income

Stock Price
4.48
Daily Change
0.06 1.36%
Monthly
13.42%
Yearly
92.27%
Q1 Forecast
4.10

Acasti Pharma reported $-938K in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Acasti Pharma USD -938K 2.42M Sep/2025
Addus HomeCare USD 29.78M 6.93M Dec/2025
Amarin USD -7.74M 6.4M Sep/2025
Cassava Sciences USD -10.81M 33.41M Sep/2025
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Option Care Health USD 58.5M 6.69M Dec/2025
Organigram Holdings CAD -37.96M 31.67M Sep/2025
Tilray USD -44.93M 44.61M Sep/2025